This event is archived. Final snapshot from when the story concluded. View on Dashboard
Tech medical breakthrough

Gothenburg Scientists Link Aging, ATF4 to Lung Cancer Spread

Analysis based on 7 articles · First reported Mar 11, 2026 · Last updated Mar 18, 2026

Sentiment
60
Attention
4
Articles
7
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

This medical breakthrough could significantly impact the biotechnology and pharmaceutical sectors by opening new avenues for targeted lung cancer therapies, especially for older patients. Companies developing drugs that modulate the integrated stress response or target ATF4 could see increased interest and investment.

Biotechnology Pharmaceuticals Healthcare

Scientists at the University of Gothenburg, led by Volkan Sayin and Clotilde Wiel, have discovered that aging alters the biological behavior of lung cancer, making it more prone to spreading. Their study, published in Nature (journal), identified a stress-response protein called ATF4, which is hijacked by tumors in older individuals to reprogram their metabolism, facilitating metastasis despite slower primary tumor growth. Higher ATF4 levels were linked to increased cancer recurrence and lower survival rates in lung adenocarcinoma patients. The researchers propose a new treatment strategy by targeting ATF4 or its controlled metabolic processes, suggesting that existing drugs previously deemed ineffective might work better if precisely applied to older patients with high ATF4 activity. This finding emphasizes the need for cancer research and drug development to focus more on the biological effects of aging.

95 University of Gothenburg identified a protein increasing lung cancer spread in older patients
90 University of Gothenburg suggested a new treatment strategy by targeting ATF4
80 University of Gothenburg published research findings in Nature (journal) Nature (journal)
ngo
The University of Gothenburg scientists identified a protein, ATF4, that increases lung cancer spread in older patients, suggesting a new treatment strategy. This discovery enhances the university's reputation in medical research.
Importance 90 Sentiment 50
per
Volkan Sayin, an Associate Professor at the University of Gothenburg, co-led the research identifying ATF4's role in lung cancer metastasis in older patients. His insights explain a clinical paradox and highlight the need for age-appropriate cancer research.
Importance 90 Sentiment 50
per
Clotilde Wiel, an Associate Professor at the University of Gothenburg, co-led the study, suggesting ATF4 as a marker for aggressive lung cancer and a target for more precise treatments. Her work indicates that certain drugs may be more effective in older patients with high ATF4 activity.
Importance 90 Sentiment 50
priv
Nature (journal) published the study by the University of Gothenburg scientists, lending credibility and broad dissemination to the findings. This publication reinforces its position as a leading scientific journal.
Importance 30 Sentiment 20
cnt
The research utilized medical data from lung cancer patients in the Swedish regions of Halland and Västra Götaland, contributing to the study's real-world applicability. This highlights Sweden's contribution to medical research.
Importance 20 Sentiment 10
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.